| Dr Eren Taydas, MD | |
|
256 Eagleview Blvd # 174, Exton, PA 19341-1157 | |
| (949) 829-3271 | |
| Not Available |
| Full Name | Dr Eren Taydas |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 256 Eagleview Blvd # 174, Exton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902164742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD463915 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pottstown Hospital | Pottstown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Gastroenterology Associates Of Lancaster, Ltd. | 4688575434 | 236 |
News Archive
CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.
A multicenter team of researchers led by Barbara Murphy, MD, of the Icahn School of Medicine at Mount Sinai has identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail. Their results were published in the July 21 edition of Lancet.
The Rowan University Foundation, the philanthropic and fundraising arm of Rowan University, committed to allocate $5 million to a new venture capital fund to fuel new research initiatives by faculty, students and alumni.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
Kaiser Health News provides a fresh take on health policy developments with "Bulk Discounts" by Bob and Tom Thaves.
› Verified 9 days ago
| Entity Name | Regional Gastroenterology Associates Of Lancaster, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154422806 PECOS PAC ID: 4688575434 Enrollment ID: O20040115000777 |
News Archive
CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.
A multicenter team of researchers led by Barbara Murphy, MD, of the Icahn School of Medicine at Mount Sinai has identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail. Their results were published in the July 21 edition of Lancet.
The Rowan University Foundation, the philanthropic and fundraising arm of Rowan University, committed to allocate $5 million to a new venture capital fund to fuel new research initiatives by faculty, students and alumni.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
Kaiser Health News provides a fresh take on health policy developments with "Bulk Discounts" by Bob and Tom Thaves.
› Verified 9 days ago
| Entity Name | Digestive Disease Associates, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699742080 PECOS PAC ID: 3375526049 Enrollment ID: O20040611001399 |
News Archive
CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.
A multicenter team of researchers led by Barbara Murphy, MD, of the Icahn School of Medicine at Mount Sinai has identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail. Their results were published in the July 21 edition of Lancet.
The Rowan University Foundation, the philanthropic and fundraising arm of Rowan University, committed to allocate $5 million to a new venture capital fund to fuel new research initiatives by faculty, students and alumni.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
Kaiser Health News provides a fresh take on health policy developments with "Bulk Discounts" by Bob and Tom Thaves.
› Verified 9 days ago
| Entity Name | Prospect Health Access Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.
A multicenter team of researchers led by Barbara Murphy, MD, of the Icahn School of Medicine at Mount Sinai has identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail. Their results were published in the July 21 edition of Lancet.
The Rowan University Foundation, the philanthropic and fundraising arm of Rowan University, committed to allocate $5 million to a new venture capital fund to fuel new research initiatives by faculty, students and alumni.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
Kaiser Health News provides a fresh take on health policy developments with "Bulk Discounts" by Bob and Tom Thaves.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eren Taydas, MD 256 Eagleview Blvd # 174, Exton, PA 19341-1157 Ph: (949) 829-3271 | Dr Eren Taydas, MD 256 Eagleview Blvd # 174, Exton, PA 19341-1157 Ph: (949) 829-3271 |
News Archive
CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.
A multicenter team of researchers led by Barbara Murphy, MD, of the Icahn School of Medicine at Mount Sinai has identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail. Their results were published in the July 21 edition of Lancet.
The Rowan University Foundation, the philanthropic and fundraising arm of Rowan University, committed to allocate $5 million to a new venture capital fund to fuel new research initiatives by faculty, students and alumni.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
Kaiser Health News provides a fresh take on health policy developments with "Bulk Discounts" by Bob and Tom Thaves.
› Verified 9 days ago
Mr. Sean G Dorrell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 860 Springdale Dr, Suite 100, Exton, PA 19341 Phone: 610-524-3703 Fax: 610-524-5990 | |
Steven J Goldstein, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 495 Thomas Jones Way, Suite 200, Exton, PA 19341 Phone: 610-644-6755 Fax: 610-647-2063 | |
Dr. Sailaja Satturu Rao, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 495 Thomas Jones Way, Suite 100, Baxter Building Ii, Exton, PA 19341 Phone: 610-524-4106 Fax: 610-524-4168 | |
Susan M. Kohli, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 93 W Devon Dr, Suite 100, Exton, PA 19341 Phone: 610-321-0200 Fax: 610-594-2625 | |
Cara Lea O'shaughnessey, D.O. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 855 Springdale Drive, Suite 120, Exton, PA 19341 Phone: 610-561-6100 Fax: 610-524-0133 | |
Dr. Herman J Michael Jr., MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 860 Springdale Dr, Suite 100, Exton, PA 19341 Phone: 610-524-3703 Fax: 610-524-5990 | |
Dr. Steven S Han, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 860 Springdale Dr, Suite 100, Exton, PA 19341 Phone: 610-524-3703 Fax: 610-524-5990 |